OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference
Rhea-AI Summary
OPKO Health (Nasdaq: OPK) will participate in the Piper Sandler 37th Annual Healthcare Conference in New York City from December 2–4, 2025. Management will hold one-on-one investor meetings and appear in a fireside discussion on December 3, 2025 at 12:00 p.m. ET. Investors who want meetings are instructed to contact their Piper Sandler representative to schedule.
Positive
- None.
Negative
- None.
News Market Reaction – OPK
In the Nov 20 session, OPK declined 0.76%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MIAMI, Nov. 19, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the Piper Sandler 37th Annual Healthcare Conference, being held December 2-4, 2025 at the Lotte New York Palace Hotel in New York City. Management will be holding one-on-one meetings with investors and will be participating in a fireside discussion on Wednesday, December 3rd at 12:00 p.m. Eastern time.
Investors interested in scheduling a meeting with OPKO management should contact their Piper Sandler representative.
About OPKO Health
OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit www.opko.com.
Contacts:
Alliance Advisors IR
Yvonne Briggs, 310-691-7100
ybriggs@allianceadvisors.com
or
Bruce Voss, 310-691-7100
bvoss@allianceadvisors.com
